phase readout
saveNCT07487740: A Food Effect Study to Evaluate the Relative Bioavailability of Nalbuphine Extended-Release Tablets (NAL ER) in Healthy Participants
RECRUITINGupdated 2mo ago
community read0 votes
Sponsor: Trevi Therapeutics. Phase: PHASE1. Conditions: Healthy Participants
view source ↗
comments(0)
5-min edit window · permanent after that